Frank Albers

Featured in: Favicon

thelancet.com Favicon

dovepress.com Favicon

healio.com Favicon

standaard.be Favicon

ersjournals.com Favicon

jacionline.org Favicon

annallergy.org Favicon

resmedjournal.com Favicon

onlinelibrary.wiley.com + 1 more

Articles

A fully decentralized randomized controlled study of as-needed albuter

Apr 30, 2024 | dovepress.com | Craig LaForce |Frank Albers |Mark Cooper |Anna Danilewicz

Back to Journals » Journal of Asthma and Allergy » Volume 17 Authors LaForce C, Albers FC , Cooper M, Danilewicz A, Dunsire L, Rees R, Cappelletti C Received 30 April 2024 Accepted for publication 31 July 2024 Published 23 August 2024 Volume 2024:17 Pages 801—811 DOI https://doi.org/10.2147/JAA.S471134 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Luis Garcia-Marcos Craig LaForce,1 Frank C Albers,2 Mark Cooper,3...
Albuterol-budesonide Fixed-dose Combination (FDC) Inhaler As-needed Reduces Progression from Symptomatic Deterioration to Severe Exacerbation in Patients with Moderate-to-severe Asthma: Analysis from MANDALA

Feb 3, 2023 | jacionline.org | Bradley Chipps |Alberto Papi |Frank Albers |Mark Cooper

Short-acting β -agonists (SABAs) treat symptoms, but not the underlying inflammation. A “window of opportunity” may exist to prevent severe exacerbations if symptoms and inflammation are treated concomitantly, as advocated by GINA and NAEPP.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →